Intracerebral Hemorrhage
Trial: NovoSeven effective in treatment of ICH
Published in Drug Week, July 30th, 2004
The phase IIb study demonstrated treatment with NovoSeven of ICH patients led to a significant reduction in hematoma growth compared to the placebo group.
Importantly, results demonstrated patients treated with NovoSeven had significantly improved neurological and functional outcome, implying a lasting patient benefit in terms of reduced disability and dependency on help. This is the first time such encouraging results have been observed in any ICH trial.
The study showed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-07-30)
More Articles from Drug Week
- AIDS Therapy
Data on Lexiva/Ritonavir vs. Nelfinavir study published - Heart Failure
sNDA submitted for Atacand for cardiovascular condition - Parkinson Disease
Favorable results presented from phase Ib/IIa trial of ACP-103 - Regulatory Issues
FDA lifts clinical hold on ocinaplon, subject to protocol review - AIDS Therapy
NDA submitted as treatment for weight loss in AIDS patients - Acute Coronary Syndromes
Two major studies show enoxaparin an effective alternative to heparin - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
